Education
About Us
Working with TipRanks
Follow Us
MSSM - ETF AI Analysis
Top Page
Morgan Stanley Pathway Small-Mid Cap Equity ETF (MSSM)
Rating:65Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown solid gains over the year so far, with especially strong returns in the most recent month and quarter.
Leading Holdings Showing Strong Momentum
Several of the top positions, such as FTAI Aviation, Bloom Energy, and Rambus, have delivered strong year-to-date performance, helping drive the fund’s results.
Broad Sector Diversification
Holdings are spread across many sectors, including industrials, technology, health care, and financials, which helps reduce the impact of weakness in any single industry.
Negative Factors
Higher Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of the returns go toward fees instead of staying in investors’ pockets.
Heavy U.S. Concentration
With the vast majority of assets in U.S. stocks and very limited exposure to other countries, the fund is heavily tied to the U.S. market’s fortunes.
Small-Mid Cap Volatility Risk
Because the ETF focuses on small- and mid-sized companies, it may experience larger price swings and sharper downturns than funds holding more large, established firms.
MSSM vs. SPDR S&P 500 ETF (SPY)
AUM721.11M
RegionNorth America
Expense Ratio0.57%
Beta0.99
IssuerMorgan Stanley
Inception DateDec 09, 2024
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume23,354
30 Day Avg. Volume27,278
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
62.71Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2252
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MSSM Summary
The Morgan Stanley Pathway Small-Mid Cap Equity ETF (MSSM) focuses on small and mid-sized U.S. companies, rather than tracking a specific index. It spreads your money across many sectors, including industrials, technology, and health care, and holds growing businesses like FTAI Aviation and Bloom Energy. Someone might invest in MSSM to seek higher long-term growth than large, established companies and to diversify beyond the biggest names in the market. A key risk is that smaller companies can be more volatile, so the ETF’s price can move up and down more sharply than the overall market.
How much will it cost me?The Morgan Stanley Pathway Small-Mid Cap Equity ETF (MSSM) has an expense ratio of 0.57%, which means you’ll pay $5.70 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on small to mid-sized companies that require more research and oversight compared to passively managed ETFs.
What would affect this ETF?The MSSM ETF, with its focus on small to mid-cap U.S. companies, could benefit from economic growth and innovation in sectors like technology and industrials, which make up a significant portion of its holdings. However, it may face challenges from rising interest rates, which can increase borrowing costs for smaller companies, and economic slowdowns that disproportionately impact less established businesses. Regulatory changes or sector-specific disruptions could also influence the performance of its top holdings.
MSSM Top 10 Holdings
MSSM is leaning into U.S. small and mid-cap growth stories, with industrial and tech names setting the tone. Bloom Energy and Rambus have been rising stars, giving the fund a lift as investors warm to clean energy and AI-related plays. Comfort Systems and TechnipFMC are also pulling their weight, reflecting strength in industrial and energy services. On the softer side, Resideo has been lagging and Ascendis Pharma looks mixed, keeping a bit of a drag on returns. Overall, the fund is diversified but still driven by a handful of high-momentum innovators.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| FTAI Aviation | 1.18% | $8.48M | $27.93B | 170.88% | 58 Neutral | |
| Ascendis Pharma | 1.05% | $7.58M | $13.81B | 73.04% | 46 Neutral | |
| TechnipFMC | 1.00% | $7.19M | $22.54B | 85.42% | 80 Outperform | |
| Comfort Systems | 0.95% | $6.85M | $40.28B | 161.50% | 80 Outperform | |
| ViaSat | 0.92% | $6.63M | $6.11B | 369.54% | 56 Neutral | |
| Bloom Energy | 0.85% | $6.10M | $35.80B | 541.94% | 62 Neutral | |
| Ormat Techno | 0.68% | $4.89M | $7.59B | 94.76% | 71 Outperform | |
| Nextpower Inc | 0.64% | $4.62M | $17.37B | 132.23% | 78 Outperform | |
| Aercap Holdings | 0.59% | $4.27M | $25.37B | 50.27% | 77 Outperform | |
| Rambus | 0.59% | $4.25M | $12.25B | 84.73% | 78 Outperform |
MSSM Technical Analysis
Neutral
―
Price Trends
51.75
Positive
50.59
Positive
47.65
Positive
Market Momentum
0.67
Positive
52.14
Neutral
23.95
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MSSM, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 53.64, equal to the 50-day MA of 51.75, and equal to the 200-day MA of 47.65, indicating a neutral trend. The MACD of 0.67 indicates Positive momentum. The RSI at 52.14 is Neutral, neither overbought nor oversold. The STOCH value of 23.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for MSSM.
MSSM Peer Comparison
Comparison Results
Performance Comparison
MSSM
Morgan Stanley Pathway Small-Mid Cap Equity ETF
53.37
6.94
14.95%
TSME
Thrivent Small-Mid Cap ESG ETF
―
―
―
RSMC
Rockefeller U.S. Small-Mid Cap ETF
―
―
―
GRNJ
Fundstrat Granny Shots US Small- & Mid-Cap ETF
―
―
―
NBSM
Neuberger Berman Small-Mid Cap ETF
―
―
―
SMIZ
Zacks Small/Mid Cap ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents